Postoperative Hypersensitivity and Digital Radiographic Assessment of a Zinc Modified Versus a Conventional Glass Ionomer Cement in Deep Carious Lesion: Randomized Controlled Clinical Trial
Primary Purpose
Carious Dentin
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Partial caries removel techniques
Sponsored by
About this trial
This is an interventional treatment trial for Carious Dentin focused on measuring Incomplete caries removel, Partial caries removel
Eligibility Criteria
Inclusion Criteria:
- Male or female (>18 y)
- patient with At least 1 deep carious lesion
- Clinical symptoms of reversible pulpitis with positive pulp response
Exclusion Criteria:
- 1. Patient suffer from irreversible pulpitis (pain with hot or instant pain lasting for a while, resistant to analgesic) 2. Presence of any sign of periapical lesion (like sinus tract ) 3. Teeth with periodontal problem 4. Anterior teeth (material used for non aesthetic region) 5. Pregnant women, to avoid multiple exposure to x ray 6. Patients unable to give consent(mentally retarted, or refuse to right a consent)
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Zinc modified glass ionomer
Conventionel glass ionomer
Arm Description
Zinc modified glass ionomer (chemfill rock) galss ionomer used as restoration for posterior teeth in case of partial caries removel
Conventional glass ionomer used as restoration for posterior teeth in case of partial caries removel
Outcomes
Primary Outcome Measures
Digital radigraphic assessment
The presence of periapical change or change in lamina dura change after the procedure
Secondary Outcome Measures
Post opreative hypersenstivity
The presence or absence of pain with thermal
Full Information
NCT ID
NCT03285022
First Posted
September 14, 2017
Last Updated
September 14, 2017
Sponsor
Cairo University
1. Study Identification
Unique Protocol Identification Number
NCT03285022
Brief Title
Postoperative Hypersensitivity and Digital Radiographic Assessment of a Zinc Modified Versus a Conventional Glass Ionomer Cement in Deep Carious Lesion: Randomized Controlled Clinical Trial
Official Title
Postoperative Hypersensitivity and Digital Radiographic Assessment of a Zinc Modified Versus a Conventional Glass Ionomer Cement in Deep Carious Lesion: Randomized Controlled Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
September 2017
Overall Recruitment Status
Unknown status
Study Start Date
October 20, 2017 (Anticipated)
Primary Completion Date
April 20, 2018 (Anticipated)
Study Completion Date
April 20, 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cairo University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The study aim to evaluate the difference between the effect of zinc modified glass ionomer and conventional glass ionomer on the success of partial caries removel technique
Detailed Description
The zinc ion has an antibacterial effect which could increase the success of partial caries removel technique by decreasing the bactrial population .
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Carious Dentin
Keywords
Incomplete caries removel, Partial caries removel
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Masking Description
Outcome assessor and participant will be blinded to the type of material
Allocation
Randomized
Enrollment
52 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Zinc modified glass ionomer
Arm Type
Experimental
Arm Description
Zinc modified glass ionomer (chemfill rock) galss ionomer used as restoration for posterior teeth in case of partial caries removel
Arm Title
Conventionel glass ionomer
Arm Type
Active Comparator
Arm Description
Conventional glass ionomer used as restoration for posterior teeth in case of partial caries removel
Intervention Type
Procedure
Intervention Name(s)
Partial caries removel techniques
Other Intervention Name(s)
Partial caries removel
Intervention Description
Removel of all superfacial dentin and leaving the inner affectted dentin
Primary Outcome Measure Information:
Title
Digital radigraphic assessment
Description
The presence of periapical change or change in lamina dura change after the procedure
Time Frame
At baseline ,3months and 6 months
Secondary Outcome Measure Information:
Title
Post opreative hypersenstivity
Description
The presence or absence of pain with thermal
Time Frame
Baseline ,at 3 months and at 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Male or female (>18 y)
patient with At least 1 deep carious lesion
Clinical symptoms of reversible pulpitis with positive pulp response
Exclusion Criteria:
1. Patient suffer from irreversible pulpitis (pain with hot or instant pain lasting for a while, resistant to analgesic) 2. Presence of any sign of periapical lesion (like sinus tract ) 3. Teeth with periodontal problem 4. Anterior teeth (material used for non aesthetic region) 5. Pregnant women, to avoid multiple exposure to x ray 6. Patients unable to give consent(mentally retarted, or refuse to right a consent)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dina Mounir Elkady, Assitant lecturer
Phone
01004297317
Email
Dina.elkady@dentistry.cu.edu.eg
First Name & Middle Initial & Last Name or Official Title & Degree
Mohamed Riad Farid, Professor
Phone
01223113166
Email
mriad_52@yahoo.com
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Postoperative Hypersensitivity and Digital Radiographic Assessment of a Zinc Modified Versus a Conventional Glass Ionomer Cement in Deep Carious Lesion: Randomized Controlled Clinical Trial
We'll reach out to this number within 24 hrs